MICRO THERAPEUTICS, INC. DBA EV3 HYPERGLIDE; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
|
Back to Search Results |
|
Model Number 104-4127 |
Device Problem
Burst Container or Vessel (1074)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/01/2023 |
Event Type
malfunction
|
Event Description
|
Medtronic received a report that the balloon was broken before it was used.The balloon looked as dropped.No patient symptoms or further complications were reported as a result of this event.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported that the physician tested the balloon prior to use.The balloon was not inflated during the test.There was no previous manipulation in the patient.The guidewire tip was advanced out of the catheter tip 3cm during the inflation.There was no leak - balloon did not inflate during the test.The contrast ratio was 50:50.The guidewire tip was not shaped.The injection rate was slow.A 1cc luer lock syringe was used during inflation/deflation of the balloon.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3.Product analysis: equipment used: vis (m-78210), 203cm ruler (m-83361), snap gauge (m-79527) as found condition: the hyperglide balloon catheter and a guidewire were returned for analysis within a shipping box; within an opened hyperglide outer carton; within a plastic bag and within dispenser tracks.Visual inspection/damage location details: the hyperglide balloon catheter was returned with guidewire extending 32.6cm from hub and 9.9cm from distal tip.No damages or irregularities were found with the hyperglide hub.No bends or kinks were found with the hyperglide catheter body.Upon visual inspection, no damages were found with the hyperglide balloon/distal tip.Testing/analysis: the guidewire proximal od (outer diameter) was measured to be 0.010 and distal od was measured to be 0.010¿.The b alloon lumen was flushed, water exited the distal tip.An attempt to inflate the balloon was made with the returned guidewire.The balloon was able to maintain inflation.No leaks were observed.No other anomalies were observed.Conclusion: based on the device analysis and reported information, the customer¿s report of ¿balloon rupture during set up¿ was unable to be confirmed.The user error may have contributed to the reported issue as it was reported that the guidewire tip was advanced out of the catheter tip 3.0cm during the inflation.Per ifu: ¿balloon cannot inflate unless a portion of the distal 10 cm of the guidewire tip is occluding the distal inflation holes of the catheter.¿ h6.Coding up dated based on analysis results.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|